In this database, useful information about carbohydrate antigens, ie, glycoepitopes, and antibodies is organized as a compact encyclopedia.
Source | Last Updated |
---|---|
GlycoEpitope | November 18, 2015 |
Epitope ID | Epitope Name | Epitope Sequence ▲ |
---|---|---|
EP0103 | Poly-KDN | (KDN)n |
EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac) n |
EP0102 | Poly-N-Glycolylneuraminic Acid | (Neu5Gc)n |
EP0506 | beta 1-4 Galactan | -[Gal(b1-4)]n- |
EP0507 | 1-6 beta Galactan | -[Gal(b1-6)]n- |
EP0500 | Homogalacturonan | -[GalA(a1-4)]n- O-acetyled and methyl-esterified GalA may exist |
EP0081 | Chondroitin | -[GlcA(b1-3)GalNAc(b1-4)]n- |
EP0086 | Heparan Sulfate | -[{[±(HSO3(-2))GlcA(b1-4)]or[±(HSO3(-2))IdoA(a1-4)]}(±(HSO3(-3))±[(HSO3 or CH3CO)(-2)]±(HSO3(-6))GlcN]n- |
EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0085 | Keratan Sulfate | -{HSO3(-6)GlcNAc(b1-3)±[HSO3(-6)]Gal(b1-4)}n- |
EP0084 | Chindroitin Sulfate D Unit | -{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0088 | Acharan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- |
EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R |
EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R |
EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
EP0057 | Fucosyl Asialo-GM1 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0049 | Fucosyl GM1 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0251 | Blood Group H Type 1 | Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R |
EP0010 | Lewis b | Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0092 | Trifucosyl-Lewis b Antigen | Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R |
EP0018 | Lewis y | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0210 | Lewis y (extended) / Hexasaccharide | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc-R |
EP0094 | Trifucosyl-Lewis y Antigen | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0280 | Fuc(a1-3)GalNAc(b1) | Fuc(a1-3)GalNAc(b1-)-R |
EP0072 | Gal-CTH | Gal(a1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0200 | Alpha-Galactosyl Epitope | Gal(a1-3)Gal(b1-4)GlcNAc-R |
EP0262 | Blood Group B Type 2 | Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-)-R |
EP0113 | Galabiosylceramide | Gal(a1-4)Gal(b1-1)Cer |
EP0071 | Gb3 | Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0045 | Pk Antigen | Gal(a1-4)Gal(b1-4)Glc-R |
EP0046 | P1 Antigen | Gal(a1-4)Gal(b1-4)GlcNAc-R |
EP0068 | Bata Galactose | Gal(b1-)-R-Cer |
EP0074 | Galactosylceramide | Gal(b1-1)Cer |
EP0020 | T Antigen | Gal(b1-3)GalNAc(a1-)Ser/Thr |
EP0039 | SSEA-3 | Gal(b1-3)GalNAc(b1-3)Gal(a1-)-R |
EP0036 | Galactosylgloboside | Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0047 | Asialo GM1 | Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0050 | GM1 | Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0059 | GD1b | Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0324 | Gal(b1-3)GalNAc | Gal(b1-3)GalNAc-R |
EP0114 | Lactotetraosylceramide | Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0322 | Lacto-N-Tetraose | Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc-R |
EP0007 | Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0090 | Dimeric Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0091 | Lewis a- Lewis x Hybrid Antigen | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0211 | Lewis a (b1-3)Gal | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal-R |
EP0078 | Lactosylceramide | Gal(b1-4)Glc(b1-1)Cer |
EP0140 | LacNAc-Gal | Gal(b1-4)GlcNAc(b1-3)Gal(b1-)-R |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024